REG - Animalcare Group PLC - Result of AGM

AnimalcareAnnouncement

27/06/2018 14:20

RNS Number : 7968S
Animalcare Group PLC
27 June 2018
 


 
27 June 2018
 
ANIMALCARE GROUP PLC
 
 ("Animalcare" or the "Company")
 
Animalcare Group plc (AIM: ANCR), the pan-European animal health business, confirms that all the resolutions put to the Annual General Meeting ("AGM") held at the offices of Panmure Gordon & Co, 1 New Change, London EC4M 9AF at 11.30am today were passed by a show of hands.  
 
Enquiries:
 




Animalcare Group plc












Chris Cardon, Chief Executive Officer






Tel: 01904 487 687




Chris Brewster, Chief Financial Officer












Panmure Gordon (UK) Ltd (Nominated Adviser & Broker)


Tel: 020 7886 2500




Corporate Finance












Freddy Crossley / Peter Steel












Corporate Broking












James Stearns












Consilium Strategic Communications 


Tel: 020 3709 5700




Amber Fennell


animalcare@consilium-comms.com




Chris Welsh








Olivia Manser








 
About Animalcare (www.animalcaregroup.co.uk)
Animalcare Group plc is a UK AIM listed veterinary sales, marketing and product development company resulting from the merger of Animalcare and Ecuphar NV.
 
Post-merger Animalcare is a pan-European animal health company, with a broad geographic footprint. The Company now has direct sales in seven countries (UK, Belgium, Netherlands, Spain, Portugal, Italy and Germany) and exports to approximately 50 markets worldwide.
 
The enlarged Company has nearly 100 sales representatives and 28 agents operating across Europe and owns 50 licensed drugs, eight vaccines and over 100 care and nutraceutical products.
 
Animalcare invests in developing its own pharmaceutical products, seeks distribution partnerships and product acquisitions.
 
For more information see Animalcare Ltd (www.animalcare.co.uk) and Ecuphar NV (www.ecuphar.com).
 
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGSEMFDWFASEFM